Drug:
Reaction: BLOOD GLUCOSE INCREASED
20250101 - 20251231
No. 201 - 300
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 201 | 25098454 |
US |
65 | 1 |
Death, Blood albumin decreased, Blood alkaline phosphatase increased, Blood calcium decreased, Blood chloride increased, Blood glucose increased, Blood testosterone decreased, Full blood count abnormal, Haematocrit decreased, Immature granulocyte count increased, Lymphocyte count decreased, Mean cell haemoglobin decreased, Mean cell haemoglobin concentration decreased, Mean platelet volume decreased, Monocyte count decreased, Neutrophil count increased, Neutrophil count decreased, Prostatic specific antigen increased, Protein total decreased, Red blood cell count decreased, Red cell distribution width increased, Serum ferritin increased, Vitamin B12 increased, White blood cell count decreased, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 202 | 25098577 |
BR |
||
Cerebrovascular accident, Myocardial infarction, Drug ineffective, Blood glucose increased, Nausea, Vomiting, Headache, Abdominal discomfort, Nocturnal fear, |
||||
DAPAGLIFLOZIN, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 203 | 25098696 |
US |
59 | 2 |
Product dose omission issue, Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 204 | 25099181 |
CA |
82 | |
Loss of consciousness, Fatigue, Blood glucose increased, Feeling abnormal, Rash pruritic, Asthenia, Hyperglycaemia, Dehydration, Acute kidney injury, |
||||
CAPIVASERTIB, CAPIVASERTIB, FULVESTRANT, FULVESTRANT, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 205 | 25099237 |
US |
||
Blood glucose increased, Abdominal discomfort, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 206 | 25099371 |
US |
2 | |
Chills, Blood glucose increased, Tremor, Gait disturbance, Blood cholesterol increased, Hot flush, Hyperhidrosis, Decreased appetite, Bone pain, Fatigue, Headache, |
||||
ANASTROZOLE, ANASTROZOLE TABLETS, PALBOCICLIB, ROSUVASTATIN, |
||||
| 207 | 25099440 |
US |
||
Stenosis, Libido decreased, Blood glucose increased, Fatigue, Diarrhoea, Feeling hot, |
||||
RELUGOLIX, RELUGOLIX, CORTISONE ACETATE, |
||||
| 208 | 25099704 |
US |
72 | 1 |
Weight decreased, Blood glucose increased, Glycosylated haemoglobin increased, Drug ineffective, Inappropriate schedule of product administration, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ORAL SEMAGLUTIDE, |
||||
| 209 | 25100452 |
US |
65 | 2 |
Respiratory disorder, Blood pressure decreased, Rash, Full blood count decreased, Platelet count decreased, Nausea, Blood glucose increased, Fatigue, Asthenia, |
||||
PALBOCICLIB, INAVOLISIB, HYDROXYZINE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ERGOCALCIFEROL, |
||||
| 210 | 25100606 |
GB |
66 | 1 |
Blood glucose increased, |
||||
PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, ABIRATERONE ACETATE, ABIRATERONE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 211 | 25100622 |
US |
43 | 2 |
Blood glucose increased, Inappropriate schedule of product administration, Maternal exposure during pregnancy, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 212 | 25100695 |
US |
57 | 1 |
Blood glucose increased, Product quality issue, |
||||
INSULIN ASPART, INSULIN GLARGINE, |
||||
| 213 | 25101263 |
JP |
90 | |
Glycosylated haemoglobin increased, Blood glucose increased, |
||||
BREXPIPRAZOLE, BREXPIPRAZOLE, |
||||
| 214 | 25101300 |
US |
67 | 1 |
Product dose omission issue, Limb mass, Oedema peripheral, Blood glucose increased, Renal impairment, Dyspnoea exertional, Blood pressure increased, |
||||
BUDESONIDE, SEMAGLUTIDE, LISINOPRIL, EMPAGLIFLOZIN, FUROSEMIDE, CARVEDILOL, |
||||
| 215 | 25101795 |
US |
82 | 2 |
Blood glucose increased, Expired product administered, |
||||
INSULIN LISPRO, |
||||
| 216 | 25102114 |
US |
71 | |
Blood glucose increased, |
||||
DULAGLUTIDE, |
||||
| 217 | 25102224 |
FR |
50 | 1 |
Blood glucose increased, Blood glucose increased, Decreased appetite, Weight decreased, Fall, Malaise, |
||||
DULAGLUTIDE, INSULIN LISPRO, INSULIN LISPRO, |
||||
| 218 | 25102435 |
US |
57 | 1 |
Injection site mass, Injection site pain, Blood glucose increased, Product administered at inappropriate site, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 219 | 25092158 |
BR |
88 | 2 |
Urinary tract infection, Myocardial infarction, Feeding disorder, Aspiration, COVID-19, Condition aggravated, Lung disorder, Renal impairment, Asthenia, Blood glucose increased, |
||||
LINAGLIPTIN, BISOPROLOL FUMARATE, |
||||
| 220 | 25092162 |
US |
79 | 1 |
Blood glucose increased, Incorrect dose administered, |
||||
DENOSUMAB, RELUGOLIX, ATENOLOL, GABAPENTIN, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, ESCITALOPRAM, ATORVASTATIN CALCIUM, MEGESTROL ACETATE, PANTOPRAZOLE, REPAGLINIDE, ERGOCALCIFEROL, RIVAROXABAN, |
||||
| 221 | 25092290 |
BR |
86 | 2 |
Myocardial infarction, Cerebrovascular accident, Renal neoplasm, Blood glucose increased, Asthenia, Condition aggravated, |
||||
EMPAGLIFLOZIN AND LINAGLIPTIN, |
||||
| 222 | 25092403 |
US |
37 | 2 |
Fatigue, Neuropathy peripheral, White blood cell count increased, Mean cell haemoglobin concentration decreased, Neutrophil count increased, Platelet count increased, Blood glucose increased, Globulins increased, Albumin globulin ratio decreased, |
||||
BEVACIZUMAB, |
||||
| 223 | 25092416 |
US |
73 | 2 |
Blood glucose increased, Haemorrhage, |
||||
INSULIN LISPRO, INSULIN ASPART, |
||||
| 224 | 25092425 |
US |
||
Blood glucose increased, |
||||
INSULIN LISPRO-AABC, |
||||
| 225 | 25092981 |
US |
71 | 2 |
Swelling, Blood glucose increased, Dyspnoea, Musculoskeletal stiffness, Hot flush, Insomnia, Chills, Hypoaesthesia, Cardiac failure congestive, Dialysis, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, SELINEXOR, CARVEDILOL, ALBUTEROL SULFATE, APIXABAN, INSULIN LISPRO, DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, METOLAZONE, INSULIN DEGLUDEC, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 226 | 25093127 |
US |
49 | 2 |
Blood glucose increased, Drug ineffective, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 227 | 25093442 |
US |
68 | 1 |
Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 228 | 25093478 |
IN |
||
Shock, Blood potassium abnormal, Blood calcium abnormal, Intentional overdose, Blood glucose increased, |
||||
AMLODIPINE, GLIMEPIRIDE, |
||||
| 229 | 25093511 |
US |
||
Cerebrovascular accident, Speech disorder, Blood glucose increased, |
||||
DAPAGLIFLOZIN, |
||||
| 230 | 25093512 |
US |
||
Blood glucose increased, Obsessive-compulsive disorder, Dyslexia, Amnesia, Anxiety, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 231 | 25093515 |
US |
||
Blood glucose increased, Circumstance or information capable of leading to medication error, |
||||
RELUGOLIX, RELUGOLIX, CYCLOBENZAPRINE, DORZOLAMIDE, SACUBITRIL AND VALSARTAN, INSULIN LISPRO, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, EMPAGLIFLOZIN, LATANOPROST, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, SEMAGLUTIDE, NETARSUDIL AND LATANOPROST OPHTHALMIC SOLUTION, 0.02%/0.005%, SILODOSIN, TRAVOPROST, TRAVOPROST (ISOMER FREE), |
||||
| 232 | 25093518 |
US |
2 | |
Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 233 | 25093817 |
IN |
42 | 2 |
Shock, Blood potassium abnormal, Blood calcium abnormal, Blood glucose increased, Intentional overdose, |
||||
GLIMEPIRIDE, AMLODIPINE, |
||||
| 234 | 25093896 |
US |
21 | 2 |
Urine ketone body, Dyspnoea, Myalgia, Nausea, Blood glucose increased, Drug ineffective, |
||||
INSULIN LISPRO, BACLOFEN, |
||||
| 235 | 25094511 |
US |
||
Pleural effusion, Illness, Nasopharyngitis, Blood glucose increased, Abdominal discomfort, |
||||
ELACESTRANT, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 236 | 25094774 |
US |
1 | |
Blood glucose increased, Poor quality product administered, |
||||
INSULIN GLARGINE, |
||||
| 237 | 25095691 |
US |
42 | 1 |
Renal transplant, Blood glucose increased, Drug ineffective, Prescription drug used without a prescription, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 238 | 25095819 |
US |
1 | |
Renal cancer, Skin cancer, Nephropathy, Blood glucose increased, |
||||
METHYLPREDNISOLONE, METHYLPREDNISOLONE, ADALIMUMAB, INSULIN DETEMIR, INSULIN ASPART, |
||||
| 239 | 25095876 |
US |
76 | 2 |
Blood glucose increased, |
||||
DULAGLUTIDE, |
||||
| 240 | 25096558 |
US |
61 | 1 |
Surgery, Blood glucose increased, Diarrhoea, |
||||
PANCRELIPASE, |
||||
| 241 | 25096714 |
US |
72 | 2 |
Blood glucose increased, Expired product administered, Blood glucose decreased, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 242 | 25096772 |
US |
69 | 2 |
Renal cancer, Blood glucose increased, Nervousness, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 243 | 25099180 |
53 | 1 | |
Mental status changes, Syncope, Sepsis, Heart rate decreased, Tachypnoea, Leukocytosis, Lung opacity, Pneumonia, Cardiomyopathy, Electrocardiogram ST-T segment abnormal, Blood glucose increased, Glomerular filtration rate abnormal, Glycosylated haemoglobin increased, Haemoglobin decreased, C-reactive protein increased, |
||||
CLOZAPINE, OXCARBAZEPINE, |
||||
| 244 | 25086747 |
MX |
52 | 2 |
Near death experience, Malaise, Hypertension, Weight increased, Nausea, Abdominal pain upper, Blood glucose increased, Product use issue, |
||||
ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, LIRAGLUTIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ENALAPRIL, LINAGLIPTIN, ERGOCALCIFEROL, |
||||
| 245 | 25086848 |
US |
71 | 1 |
Blood glucose increased, Expired product administered, Tooth disorder, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, SEMAGLUTIDE, |
||||
| 246 | 25086973 |
US |
59 | 2 |
Hernia repair, Glycosylated haemoglobin increased, Nausea, Blood glucose increased, |
||||
SEMAGLUTIDE, |
||||
| 247 | 25087209 |
US |
61 | |
Incorrect dose administered, Injection site pain, Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 248 | 25087215 |
US |
76 | 2 |
Blood glucose increased, Product dose omission issue, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 249 | 25087225 |
US |
64 | 1 |
Blood glucose increased, Dry mouth, Vision blurred, |
||||
INSULIN LISPRO, |
||||
| 250 | 25087382 |
US |
72 | 1 |
Blood glucose increased, |
||||
APIXABAN, |
||||
| 251 | 25087454 |
US |
||
Ear operation, Blood glucose increased, |
||||
INSULIN ASPART INJECTION, INSULIN ASPART, |
||||
| 252 | 25087479 |
US |
2 | |
Crohn^s disease, Blood glucose increased, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, |
||||
| 253 | 25087605 |
US |
76 | 2 |
Weight increased, Accidental underdose, Injection site pain, Visual impairment, Decreased appetite, Drug ineffective, Glycosylated haemoglobin increased, Blood glucose increased, |
||||
DULAGLUTIDE, DULAGLUTIDE, DULAGLUTIDE, DULAGLUTIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 254 | 25087608 |
US |
79 | 2 |
Blood glucose increased, Blood glucose decreased, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 255 | 25088392 |
US |
73 | 2 |
Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 256 | 25088562 |
US |
||
Porcelain gallbladder, Ocular discomfort, Fatigue, Blood glucose increased, |
||||
RELUGOLIX, RELUGOLIX, CARVEDILOL, APIXABAN, DAPAGLIFLOZIN, TAMSULOSIN HYDROCHLORIDE, INSULIN LISPRO, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, TELMISARTAN, CLOPIDOGREL, PANTOPRAZOLE SODIUM, SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL POWDER,, SIMVASTATIN, DULAGLUTIDE, ERGOCALCIFEROL, SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL CITRATE, SILDENAFIL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CARVEDILOL, APIXABAN, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, TAMSULOSIN HYDROCHLORIDE, TELMISARTAN, ERGOCALCIFEROL, |
||||
| 257 | 25088594 |
US |
||
Blood glucose increased, Incorrect dose administered, Product dose omission issue, |
||||
RELUGOLIX, AMLODIPINE, ATENOLOL, DICYCLOMINE HYDROCHLORIDE, GABAPENTIN, HYDROCHLOROTHIAZIDE, INSULIN DETEMIR, LOSARTAN, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, ROSUVASTATIN, TIZANIDINE, DULAGLUTIDE, |
||||
| 258 | 25088640 |
US |
53 | |
Blood glucose increased, Incorrect dose administered, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 259 | 25088643 |
US |
54 | 2 |
Visual impairment, Incorrect dose administered, Blood glucose increased, Drug ineffective, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, |
||||
| 260 | 25088844 |
US |
||
Pyrexia, Blood glucose increased, Gait disturbance, Malaise, |
||||
RAVULIZUMAB, PREDNISONE, PREDNISONE, PREDNISONE, |
||||
| 261 | 25088874 |
US |
90 | 2 |
Blood glucose increased, |
||||
INSULIN GLARGINE, |
||||
| 262 | 25089003 |
US |
66 | 2 |
Blood glucose increased, Dry mouth, Weight decreased, Hypophagia, Stomatitis, |
||||
PALBOCICLIB, INAVOLISIB, |
||||
| 263 | 25089186 |
US |
25 | 2 |
Blood glucose increased, |
||||
DULAGLUTIDE, |
||||
| 264 | 25089189 |
US |
73 | 1 |
Blood glucose increased, Blood glucose decreased, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 265 | 25089190 |
US |
||
Diabetic ketoacidosis, Blood glucose increased, Drug ineffective, |
||||
DULAGLUTIDE, |
||||
| 266 | 25089196 |
US |
68 | 2 |
Blood pressure increased, Retinal injury, Cataract, Blood glucose increased, Dizziness, Arthritis, Eye swelling, Blood glucose decreased, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 267 | 25089210 |
US |
50 | 2 |
Diabetic coma, Blood glucose increased, Loss of consciousness, Blood glucose decreased, Body temperature decreased, Blood glucose increased, Memory impairment, Blood glucose decreased, Visual impairment, Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN HUMAN, INSULIN GLARGINE, |
||||
| 268 | 25089867 |
US |
84 | 2 |
Vision blurred, Dizziness, Tremor, Product storage error, Blood glucose increased, Arthralgia, Nausea, Headache, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 269 | 25090314 |
US |
62 | 2 |
Blood glucose decreased, Drug ineffective, Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 270 | 25090749 |
US |
61 | 1 |
Blood glucose increased, Product dose omission issue, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 271 | 25090916 |
US |
50 | 2 |
Drug ineffective, Blood glucose increased, Dysgeusia, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 272 | 25090919 |
US |
10 | 1 |
Blood glucose increased, Pollakiuria, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 273 | 25090947 |
82 | 1 | |
Chest pain, Dyspnoea, Dehydration, Diarrhoea, Weight decreased, Blood glucose increased, |
||||
TAFAMIDIS, TORSEMIDE, POLYETHYLENE GLYCOL 3350, |
||||
| 274 | 25081740 |
CO |
62 | 1 |
Skin laceration, Toe amputation, Pyrexia, Blood creatinine increased, Blood glucose increased, |
||||
INSULIN DETEMIR, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 275 | 25081754 |
EG |
627 | 1 |
Retinal disorder, Dementia Alzheimer^s type, Hypoglycaemic coma, Blood glucose fluctuation, Blood glucose increased, |
||||
INSULIN GLARGINE, NEBIVOLOL, NEBIVOLOL HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 276 | 25081794 |
US |
73 | 2 |
Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 277 | 25081860 |
US |
48 | |
Gastric bypass, Blood glucose increased, |
||||
INSULIN DEGLUDEC, SEMAGLUTIDE, |
||||
| 278 | 25081901 |
CN |
1 | |
Blood glucose increased, Urine ketone body present, |
||||
RIVAROXABAN, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, AMLODIPINE BESYLATE, DULAGLUTIDE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, |
||||
| 279 | 25082185 |
US |
68 | 2 |
Memory impairment, Thirst, Pruritus, Erythema, Somnolence, Fatigue, Asthenia, Decreased appetite, Blood glucose increased, Alopecia, |
||||
BEVACIZUMAB-AWWB, BEVACIZUMAB, PEMBROLIZUMAB, PACLITAXEL, CARBOPLATIN, PALONOSETRON, PALONOSETRON HYDROCHLORIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, FOSAPREPITANT, FOSAPREPITANT DIMEGLUMINE, CETIRIZINE HYDROCHLORIDE, FAMOTIDINE, |
||||
| 280 | 25082547 |
US |
47 | |
Syncope, Blood glucose increased, Device breakage, Wrong technique in product usage process, |
||||
INSULIN ASPART, |
||||
| 281 | 25082742 |
GB |
66 | 1 |
Blood glucose increased, |
||||
PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ABIRATERONE ACETATE, ABIRATERONE, |
||||
| 282 | 25082743 |
US |
51 | 1 |
Dyspnoea, Chest discomfort, Fatigue, Blood glucose increased, |
||||
PEGLOTICASE, PEGLOTICASE, PEGLOTICASE, |
||||
| 283 | 25083099 |
US |
75 | 2 |
Incorrect dose administered, Blood glucose increased, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 284 | 25083568 |
US |
||
Nasopharyngitis, Hot flush, Weight increased, Blood glucose increased, |
||||
RELUGOLIX, RELUGOLIX, |
||||
| 285 | 25083819 |
US |
||
Incorrect product administration duration, Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN HUMAN, |
||||
| 286 | 25084132 |
IN |
42 | 2 |
Shock, Blood potassium abnormal, Blood calcium abnormal, Blood glucose increased, Intentional overdose, |
||||
AMLODIPINE, GLIMEPIRIDE, |
||||
| 287 | 25084228 |
US |
56 | 2 |
Blood glucose increased, Brain fog, Somnolence, Feeling abnormal, Product storage error, Incorrect dose administered, Vision blurred, Fatigue, |
||||
DULAGLUTIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, EMPAGLIFLOZIN, |
||||
| 288 | 25084477 |
US |
70 | 1 |
Blood glucose increased, Illness, |
||||
INSULIN LISPRO, INSULIN DEGLUDEC, |
||||
| 289 | 25084686 |
US |
73 | 2 |
Blood glucose increased, |
||||
INSULIN GLARGINE, |
||||
| 290 | 25084693 |
CN |
60 | 2 |
Retinal haemorrhage, Blood glucose abnormal, Blood glucose increased, Incorrect dose administered, Incorrect dose administered, Blood glucose decreased, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN HUMAN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 291 | 25085069 |
US |
2 | |
Renal impairment, Blood pressure decreased, Malaise, Blood glucose increased, Vision blurred, Weight increased, Unevaluable event, Headache, Decreased appetite, Diarrhoea, Cortisol decreased, |
||||
LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, SPIRONOLACTONE, EMPAGLIFLOZIN, |
||||
| 292 | 25085269 |
|||
Blood pressure increased, Blood glucose increased, Insomnia, |
||||
ALBUTEROL SULFATE AND BUDESONIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 293 | 25085396 |
US |
1 | |
Dawn phenomenon, Poor quality sleep, Night sweats, Blood glucose increased, Headache, |
||||
GLIPIZIDE, |
||||
| 294 | 25085443 |
US |
80 | 2 |
Blood glucose increased, |
||||
INSULIN LISPRO, DULAGLUTIDE, |
||||
| 295 | 25086027 |
US |
77 | 1 |
Dysphagia, Metastases to central nervous system, White blood cell count decreased, Blood glucose increased, |
||||
PALBOCICLIB, PALBOCICLIB, FULVESTRANT, |
||||
| 296 | 25086164 |
US |
37 | 2 |
Blood glucose increased, Pain, Musculoskeletal stiffness, Fatigue, |
||||
TOFACITINIB, |
||||
| 297 | 25089718 |
|||
Product use issue, Insurance issue, Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 298 | 25081273 |
US |
66 | 2 |
Headache, Feeling abnormal, Liquid product physical issue, Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 299 | 25081369 |
US |
||
Blood glucose increased, |
||||
EMPAGLIFLOZIN, |
||||
| 300 | 25081466 |
US |
67 | 2 |
Product dose omission issue, Blood glucose increased, Malaise, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28